The 2019 transfusion-transmissible infections in Australia surveillance report is now available and can be found here.
The bedside transfusion support tool that all residents need has been updated and now includes more tools and resources to promote safe transfusion practice.
Now available is an updated version of Pack Check which helps a final identity check of the patient and blood product at the patient's side immediately before a transfusion.
The Blood Component Information: An extension of blood component labels (BCI) booklet has been updated and is now available online at transfusion.com.au
From Monday 1 July, we will be introducing new national sample collection guidelines and two new forms which have been developed to facilitate a standard approach to requesting platelet and neutrophil testing/investigations.
We'd be keen to hear your feedback in a 2-minute survey about iTransfuse and what else you would like to see included in this comprehensive bedside tool.
In 2018 alone, we had more than 300,000 visitors to transfusion.com.au with the most popular page visited being 'Inheritance patterns of blood groups'.
Lewis glycolipids are passively adsorbed onto the surface of red cells which we can detect as the Lewis antigens. During pregnancy the amount of Lewis antigens changes and patients may be mis-typed.
The latest audit - the Transfusion Documentation Audit - is now available for the 420 registered users.
From 28 March 2019, we will be modifying our collection and manufacturing processes to produce apheresis platelets suspended in platelet additive solution (PAS).
There has been an outbreak of a novel (new) coronavirus (referred to as SARS-CoV-2) that has been associated with cases of severe respiratory illness such as pneumonia. Symptoms of this disease (known as COVID-2019) include fever, malaise, dry cough, sore throat and shortness of breath. There is evidence of person-to-person transmission. On 11 March 2020, the World Health Organization upgraded the status of the COVID-19 outbreak from epidemic to pandemic.
The Blood Service now provides Non-Invasive Prenatal Analysis (NIPA) for blood group genotyping to determine the RhD status of the fetus.
To ensure the Blood Service has adequate supplies of RhD Immunoglobulin, the Blood Service is searching for new plasma donors who have pre-existing anti-D.
The 2018 transfusion-transmissible infections in Australia surveillance report is now available and can be found here.